MCC
SUPN icon

Money Concepts Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Money Concepts Capital’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-54
Closed -$1.93K – 2600
2022
Q4 		$1.93K Buy
54
+4
+8% +$139 ﹤0.01% 2698
2022
Q3 		$2K Hold
50
– – ﹤0.01% 1415
2022
Q2 		$1K Sell
50
-4
-7% -$115 ﹤0.01% 1398
2022
Q1 		$2K Buy
+54
New +$1.66K ﹤0.01% 2491

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Money Concepts Capital's SUPN Position: Q1 2023 in Review

Money Concepts Capital sold out of Supernus Pharmaceuticals (SUPN) in Q1 2023, closing a stake of 54 shares — an estimated $1.93K sold.

Money Concepts Capital first reported a position in SUPN in Q1 2022 and held it in 4 quarters. The position peaked at $2K in Q3 2022. 258 funds tracked by Wall St. Rank hold SUPN as of Q1 2023.

  • Money Concepts Capital reported no remaining Supernus Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 54 Supernus Pharmaceuticals shares in Q1 2023, an estimated $1.93K.
  • Money Concepts Capital first reported a position in Supernus Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • Money Concepts Capital's Supernus Pharmaceuticals position peaked at $2K in Q3 2022.
  • 258 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.